Melvin Reichman of the LIMR Chemical Genomics Center Inc. in the U.S., working with Vicky Avery of the Eskitis Institute for Cell and Molecular Therapies in Australia, will develop and validate a new drug screening approach called Ultra-High Throughput Screening for Synergy (uHTSS) to discover new drug combinations from the Tres Cantos anti-malarial set for the treatment of malaria.
Grant ID
OPP1067826
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False